ロード中...

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study

Performance-based cognitive data were collected using the Cognitive Drug Research System in a study of levomilnacipran extended-release (ER) 40–120 mg/day (NCT01034462) in adults with major depressive disorder. These data were analyzed post-hoc to explore the relationship between cognitive measures,...

詳細記述

保存先:
書誌詳細
出版年:Int Clin Psychopharmacol
主要な著者: Wesnes, Keith A., Gommoll, Carl, Chen, Changzheng, Sambunaris, Angelo, McIntyre, Roger S., Harvey, Philip D.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams And Wilkins 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265686/
https://ncbi.nlm.nih.gov/pubmed/27861191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000157
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!